Skip to search formSkip to main contentSkip to account menu

Posaconazole:MCnc:Pt:Ser/Plas:Qn

Known as: Posaconazol:Massa concentratie:Moment:Serum of plasma:Kwantitatief, Posaconazole SerPl-mCnc, Posaconazola:MCnc:Pt:Sor/Plas:Qn 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Objectives This study describes therapeutic drug monitoring (TDM) of posaconazole suspension and modified release (MR) tablets in… 
2018
2018
  • C. Fietz
  • Gesundheitsökonomie & Qualitätsmanagement
  • 2018
  • Corpus ID: 86599291
Grau S et al. Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in… 
2011
2011
Background: Posaconazole is an azole antifungal agent with a broad spectrum of activity and a manageable side-effect profile… 
Review
2010
Review
2010
  • H. Lipp
  • British Journal of Clinical Pharmacology
  • 2010
  • Corpus ID: 43704675
In recent years, the antifungal triazole posaconazole has become increasingly important for the prophylaxis and treatment of… 
Highly Cited
2008
Highly Cited
2008
ABSTRACT We compared the efficacy of combination posaconazole-liposomal amphotericin B (LAmB) therapy to monotherapy with either… 
Highly Cited
2008
Highly Cited
2008
ABSTRACT A four-part, randomized, crossover study with healthy subjects evaluated the effects of gastric pH, the dosing frequency… 
2006
2006
Objective: To report a pediatric case of posttraumatic fungal fasciitis treated successfully with a combination including… 
Review
2005
Review
2005
Cerebral phaeohyphomycosis caused by Ramichloridium mackenziei is universally fatal. All reported cases with long-term follow-up…